The article highlights three undervalued stocks in the transportation, broadcasting, and digital commerce sectors that offer potential investment opportunities despite recent market volatility.

The global airport kiosk market is expected to grow from $3.3 billion in 2023 to $5.8 billion by 2033, driven by technological advancements and increasing passenger traffic. Kiosks are enabling self-service and enhancing the travel experience, leading to their widespread adoption by airports.

NCR Voyix's (VYX) short interest has risen to 13.49% of its float, higher than its peer group average of 9.08%. This increase in short interest could be a bearish signal, as it indicates that more investors are betting against the company's stock performance.

Payments processor NCR Voyix is exploring the sale of its digital banking business, which could fetch up to $3 billion. The company has tapped Goldman Sachs to solicit interest from potential buyers, including private equity firms and other payments processors.

VYX earnings call for the period ending March 31, 2024.

IonQ (IONQ) delivered earnings and revenue surprises of 26.92% and 8.31%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?

NCR Voyix (VYX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Q2 Holdings (QTWO) teams up with the Los Angeles Police Federal Credit Union to provide digital banking services for law enforcement members.

Q2 Holdings (QTWO) secures a contract from Blaze Credit Union to support the latter with digital banking technology and ensure a unique and personalized digital banking experience.

March kicked off on a high note on Wall Street Friday, with both the S&P 500 and Nasdaq 100 indices soaring to unprecedented heights, fueled by the unstoppable surge of tech stocks. Despite the sharper-than-expected contraction revealed by the ISM Manufacturing PMI in February – with the overall index plummeting from 49.5 to 47.8, missing the anticipated 49.1 – investors remained upbeat. The data triggered downward pressure on the dollar and Treasury yields, maintaining firm expectations for Federal Reserve rate cuts. Fed speakers – including Goolsbee, Waller and Bostic – offered a mixed bag of remarks, though collectively acknowledging the ongoing progress toward disinflation. Additionally, a Fed report highlighted that inflation expectations broadly align with the 2% target. In the tech sector, the semiconductor industry continued its remarkable performance, buoyed by escalating demand for chips associated with artificial intelligence. The industry benchmark, as monitored by the iShares Semiconductor ETF (NASDAQ:SOXX), surged 3.7% following a 2.7% leap on Thursday, marking its highest level since inception. Among the Magnificent Seven, Apple ...Full story available on Benzinga.com

Shares of Zscaler, Inc. (NASDAQ: ZS) shares fell sharply during Friday’s session following second-quarter results. Zscaler posted better-than-expected earnings and sales results for its second quarter on Thursday. The company said it expects fiscal year 2024 non-GAAP income from operations between $395 million and $400 million and net income per share between $2.73 and $2.77. Zscaler shares fell 10.1% to $217.43 on Friday. Here are some other stocks moving in today's mid-day session. Gainers BioVie Inc. (NASDAQ: BIVI) shares climbed 96.1% to $2.4319. BioVie's Ne3107 demonstrated potential improvements in motor and non-motor symptoms for Parkinson's disease patients and may be realigning physiological processes for Alzheimer's patients. Adial Pharmaceuticals, Inc. (NASDAQ: ADIL) gained 68.4% to $3.4350. Adial Pharmaceuticals was awarded a new patent covering AD04 for the potential treatment of opioid use disorder. Cardiff Oncology, Inc. (NASDAQ: CRDF) shares rose 41.5% to $2.50 after the company reported better-than-expected fourth-quarter financial results, provided a clinical update on the Phase 2 randomized second-line ONSEMBLE trial in patients with RAS-mutated mCRC and announced the first patient was dosed in the randomized first-line RAS-mutated mCRC trial. Minim, Inc. (NASDAQ: MINM) shares rose 41.4% to $6.09. On Feb. 20, Minim entered into an employment agreement with David Lazar to engage him as CEO, CFO, following resignation of Jeremy Hitchcock. The RealReal, Inc. (NASDAQ: REAL) gained 39.1% to $2.4613 following upbeat quarterly results. Nxu, Inc. (NASDAQ: NXU) shares gained 36.4% to $1.09 after the company announced it successfully charged a Tesla Cybertruck on Feb. 26. Jaguar Health, Inc. (NASDAQ: JAGX) climbed 35.3% to $0.0798. Dell Technologies Inc. (NYSE: DELL) rose 26.3% to $119.52 as the company reported better-than-expected fourth-quarter financial results and increased its annual cash dividend by 20%. Sweetgreen, Inc. (NYSE: SG) gained 26% to $16.05 after the company reported better-than-expected fourth-quarter financial results. MMTec, Inc. (NASDAQ: MTC) climbed 25% to $1.61. Everbridge, Inc. (NASDAQ: EVBG) rose 24.5% to $35.19 after it amended and restated the previously announced merger agreement with Thoma Bravo. NetApp, Inc. (NASDAQ: NTAP) shares gained 24.4% to $110.85 after the company reported better-than-expected third-quarter financial results ...

VYX earnings call for the period ending December 31, 2023.